Is Teva about to sell off this divisional unit?

Some pretty strong hints on today's Town Hall call have us wondering. Respiratory franchise numbers weren't even shown on the call let alone their impact to the bottom line. Just not sure there would be buyers in the market for Digihaller or Cinqair.

 

The company is laying this division off.

 

HR/management must sit on this board and keep pushing the stupid Teva Blows threads to the top to cover up the information they don't want out.

This division is done. Kaput. Going to be zeroed out.

 

The short answer is YES. but the shortest answer is that they have quietly tried, but no one wants to pay anything for it.

 

The real answer is no. The launch of new Digihaler products and expected growth of brands as stated from Sr. leaders. This division is NOT going away, it is rapidly becoming more important for the short and long term.

 

Digihaler will save the franchise

 

For last poster, please god, confer some brains on him/her. ICS/LABA, LAMA will be heavily generic by this time next year, SABA already there, new triples have mortality data. Perhaps apply to McDonalds for a strategic french fry marketing position. DIGIHALER???? Ha!

 

What?